The importance of new companies for drug discovery: Origins of a decade of new drugs

Nature Reviews Drug Discovery

Volumn 9, Issue 11, 2010, Pages 867-882

  Kneller, Robert ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; ORPHAN DRUG;

AUSTRALIA; BIOTECHNOLOGY; CANADA; COMMERCIAL PHENOMENA; DATA ANALYSIS; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; EUROPE; FOOD AND DRUG ADMINISTRATION; FRANCE; GERMANY; JAPAN; PRIORITY JOURNAL; REVIEW; SWITZERLAND; UNITED KINGDOM; UNITED STATES;

ANIMALS; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78049467253     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3251     Document Type: Review

References (25)

1. Pisano, G. P. Science Business: The Promise, the Reality and the Future of Biotech (Harvard Business School Press, Boston, 2006).
2. Lawrence, S. Biotech drugs blaze a trail. Nature Biotechnol. 24, 736 (2006).
3. Natanson, L. & van Brunt, J. 20 compounds that defined biotech. Signals Magazine [online] (27 Jun 2008).
4. Munos, B. Lessons from 60 years of pharmaceutical innovation. Nature Rev. Drug Discov. 8, 959-968 (2009).
5. Kneller, R. Correspondence: The origin of new drugs. Nature Biotechnol. 23, 529-530 (2005).
6. Kneller, R. Correspondence: The national origins of new drugs. Nature Biotechnol. 23, 655-656 (2005).
7. Haffner, M. E. Adopting orphan drugs \-two dozen years of treating rare diseases. N. Engl. J. Med. 354, 445-447 (2006).
8. Kneller, R. W. in Reconfiguring Knowledge Production: Changing Authority Relations in the Sciences and Their Consequences for Intellectual Innovation (eds Whitley, R., Gläser, J. & Engvall, L.) 110-145 (Oxford University Press, Oxford, 2010).
9. Kneller, R. in Changing Governance of the Sciences: the Advent of Research Evaluation Systems (eds Whitley, R. & Glaser, J.) 51-73 (Springer, Dordecht, 2007).
10. Normile, D. Older scientists win majority of funding. Science 303, 1746 (2004).
11. Kneller, R. Bridging Islands: Venture Companies and the Future of Japanese and American Industry 42-167, 232-376 (Oxford University Press, Oxford, 2007).
12. Mervis, J. And then there was one. Science 321, 1622-1628 (2008).
13. Saxenian, A. Regional Advantage: Culture and Competition in Silicon Valley and Route 128 1-19, 105-259 (Harvard University Press, Cambridge, 1996).
14. Hyde, A. Working in Silicon Valley: Economic and Legal Analysis of a High Velocity Labor Market (M. E. Sharpe, Armonk NY, 2003).
15. Christensen, C. M. The rigid disk drive industry: a history of commercial and technological turbulence. Bus. Hist. Rev. 67, 531-588 (1993).
16. Zucker, L. G. & Darby, M. R. Costly information: firm transformation, exit or persistent failure. Am. Behav. Sci. 39, 959-974 (1997).
17. Garnier, J.-P. Rebuilding the R & D engine in Big Pharma. Harvard Bus. Rev. 86, 68-76 (2008).
18. Saxenian, A. The New Argonauts: Regional Advantage in a Global Economy 1-121, 125-138 (Harvard University Press, Cambridge, 2006).
19. Frantz, S. 2004 approvals: the demise of the blockbuster? Nature Rev. Drug Discov. 4, 93-94 (2005).
20. Hughes, B. Pharma pursues novel models for academic collaboration. Nature Rev. Drug Discov. 7, 631-632 (2008).
21. Jarvis, L. M. New deal: seeking closer ties, drug companies and universities shake up the model for research alliances. Chem. Eng. News 86, 13-20 (2008).
22. Kneller, R. Autarkic drug discovery in Japanese pharmaceutical companies: insights into national differences in industrial innovation. Res. Policy 32, 1805-1827 (2003).
23. Rader, R. A. Biopharmaceutical Products in the U.S. and European Markets. 6th edn Vols 1 & 2 (Bioplan Associates, Maryland, 2007).
24. Savarino, A. A historical sketch of the discovery and development of HIV-1 integrase inhibitors. Expert Opin. Investig. Drugs 15, 1507-1522 (2006).
25. Sternitzke, C., Bartkowski, A. & Schramm, R. Visualizing patent statistics by means of social network analysis tools. World Patent Inf. 30, 115-131 (2008).